The current retail prices for Ozempic, Wegovy, and Rybelsus are between $1,300 and $1,900 monthly
Ongoing Support and Monitoring: Regular follow-up visits to track your progress, discuss any challenges, and adjust your plan as needed
However, careful clinical assessment is needed before initiating therapy, particularly regarding gastrointestinal function and concurrent MS medications
The FDA announced that Ozempic and Wegovy supply problems had ended and set final deadlines for pharmacies to stop making compounded semaglutide: Individual pharmacy locations: Required to stop by April 22, 2025 Commercial compounding operations: Discontinue production by May 22, 2025 So, compounded semaglutide was not available after May 22, 2025, except in exceptional medical circumstances where standard formulations are ineffective
The transparent pricing pitch is potentially undermined by the hidden $80 consult fee, and there is currently no coaching, community, dietitian, or independent review track record available